欧洲栓塞剂市场预测至 2028 年 - COVID-19 影响和区域分析(按产品)(线圈、塞子、珠子/颗粒、可拆卸球囊、胶水、海绵、液体栓塞剂、硬化剂、沉淀剂等)、应用(肿瘤学、神经病学) 、泌尿科、心脏病科、周围血管疾病等)和最终用户(医院、心脏中心、门诊手术中心等)

TIPRE00026128 | Pages: 175 | Medical Device | Nov 2021 | Type: Regional | Status: Published

市场介绍

欧洲栓塞剂市场包括德国、法国、英国、西班牙、意大利和欧洲其他国家。欧洲在全球栓塞剂市场中占据重要地位,预计在预测期内将出现强劲的增长率。由于人口老龄化、癌症和脑动脉瘤患病率的增加以及产品发布数量的增加,预计该地区的市场将增长,这可能是推动欧洲该市场增长的主要因素。脑动脉瘤可能进一步导致大脑出血,即出血性中风。近年来,德国的中风患病率有所记录。根据伦敦国王学院为欧洲中风联盟所做的《欧洲中风负担》报告中公布的数据,中风发病率约为88,922例,即德国每年每10万居民中有51.7例中风。德国的中风患病率约为 526,774 人,每 10 万居民中有 338.5 人中风。该国的中风死亡率也很高,每年有75,861人死于中风。据估计,到 2035 年底,德国中风的发病率预计将增加 30%。此外,到 2035 年,患病率和死亡率预计将分别上升至 19% 和 40%。一些常见的危险因素导致中风的因素包括高血压、吸烟、高胆固醇和血糖水平升高。该国的市场参与者也专注于推出创新产品。预计此类发展也将加速市场增长。例如,2020 年 4 月,神经血管疾病创新技术先驱 Phenox GmbH 推出了新型 p64 MW 流量调节装置。 p64 MW 流量调节装置是一种下一代类似支架的装置,旨在将血流从动脉瘤中转移出来

在欧洲、意大利、西班牙和法国报告的 COVID-19 病例数量最多。根据欧洲疾病预防和控制中心 (ECDC) 的数据,截至 2021 年 6 月,欧洲迄今已有 736,553 人死于 COVID-19。欧洲各国在今年年初成功缓解疫情后,Covid-19 病例再次出现。许多国家每天宣布的病例数比第一波大流行期间报告的每日病例数还多。根据 ECDC 的说法,英国、西班牙、意大利和爱尔兰正在重新实施封锁。此外,许多国家政府正在努力提高细胞治疗、基因治疗和再生医学的能力。此外,在英国,癌症和神经系统疾病的治疗方法也发生了变化。由于医务人员的多样化以及集中治疗危重病人的决定,COVID-19 的增加影响了疾病的诊断和治疗。许多研究组织更加关注新冠病毒研究,并努力更好地了解该病毒。欧洲神经病学学会 (EAN) 启动了一项针对 COVID-19 患者神经系统症状的调查,以更好地了解该疾病的神经系统表现。因此,对 SARS-CoV-2 的日益关注限制了过去两年欧洲栓塞剂市场的增长。

市场概况和动态

欧洲栓塞剂市场预计将从2021年的7.9579亿美元增长到2028年的12.8295亿美元;预计 2021 年至 2028 年复合年增长率为 7.1%。 2021 年 9 月,美敦力(Medtronic)栓塞装置遭遇另一起 I 级召回的分离弹簧圈。在收到 59 起故障、10 人严重受伤和 2 人死亡的报告后,FDA 将美敦力用于治疗脑动脉瘤的 Pipeline Flex 栓塞装置的另一次召回列为 I 级事件。 2021 年 7 月,Terumo 推出新型 AZUR 血管塞和 PG Pro 外周微导管栓塞系统,这是第一个也是唯一一个与微导管兼容的塞,能够闭塞直径达 8 毫米的动脉。 Terumo 广泛的栓塞产品组合的最新成员建议用于外周脉管系统的动脉,以限制或阻止血流。此外,2021年5月,上海微创神经科技有限公司的Numen线圈栓塞系统(Numen)和Numen FR线圈脱离系统(Numen FR)获得欧盟CE认证。这些用于治疗颅内动脉瘤的弹簧圈栓塞手术。该公司专注于研发活动,开发脑血管和神经干预方面的创新解决方案。此外,泰尔茂公司于2020年12月在日本推出了囊内动脉瘤治疗装置WEB Embolization System(日本产品名称:Woven EndoBridge Device)。 WEB装置是一种创新的囊内血流干扰装置,为脑动脉瘤病例提供了新的治疗选择。这种基于现代技术的进步可能会在未来几年为欧洲栓塞剂市场引入新的未来趋势。

关键细分市场

根据产品,市场分为线圈、珠子/颗粒、塞子、可拆卸气球、胶水、海绵、液体栓塞剂、硬化剂、沉淀剂、其他的。 2020 年,珠子/颗粒细分市场占据了最大的市场份额。根据线圈,市场分为可拆卸线圈和可推动线圈。可推动的线圈细分市场在 2020 年占据了最大的市场份额。根据珠子/颗粒,市场分为球形和非球形。 2020年,可推动的非球形细分市场占据了最大的市场份额。根据应用,市场分为神经病学、肿瘤学、心脏病学、周围血管疾病等。 2020年,肿瘤学领域可能会占据最大的市场份额。按最终用户划分的栓塞剂市场分为医院、门诊手术中心、心脏中心等。 2020年,医院细分市场占据最大市场份额。

主要来源和上市公司

准备本欧洲栓塞剂市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培(Abbott);波士顿科学公司;库克医疗有限责任公司;德普合成公司;钟化株式会社;美敦力;梅里特医疗系统公司;半影公司;史赛克公司;以及 Terumo Corporation 等

购买报告的理由

  • 了解欧洲栓塞剂市场格局并确定最有可能保证丰厚回报的细分市场
  • 了解欧洲栓塞剂市场不断变化的竞争格局,保持领先地位
  • 有效规划并购和合作伙伴关系通过识别最有前景的细分市场来交易欧洲栓塞剂市场
  • 通过对欧洲栓塞剂各个细分市场表现的敏锐和全面的分析,帮助做出明智的业务决策代理商市场
  • 获取欧洲地区2021-2028年各个细分市场的市场收入预测
  • ul>

    欧洲栓塞剂市场细分

    按产品

    • 线圈
      • 可拆卸线圈
      • 可推动线圈
    • 珠子/颗粒
      • 球形
      • < span>非球形
    • 插头
    • 可拆卸气球
    • 胶水
    • 海绵
    • 液体栓塞
    • 硬化剂
    • 沉淀剂
    • 其他

     

    通过申请

    • 肿瘤学
    • 神经学
    • 泌尿科
    • 心脏病学
    • 周围血管疾病
    • 其他

    作者最终用户

    • 医院
    • 心脏中心
    • 门诊手术中心
    • 其他

    按国家/地区

    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区

    公司简介

    • 雅培
    • 波士顿科学公司
    • 库克医疗有限责任公司
    • DePuy Synthes
    • KANEKA CORPORATION
    • 美敦力
    • Merit Medical Systems Inc
    • Penumbra, Inc.
    • Stryker Corporation
    • Terumo Corporation

1.           Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Europe Embolization Agents Market – By Product

1.3.2        Europe Embolization Agents Market – By Application

1.3.3        Europe Embolization Agents Market – By End User

1.3.4        Europe Embolization Agents Market – By Country

2.           Europe Embolization Agents Market – Key Takeaways

3.       Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Europe Embolization Agents Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        Europe– PEST Analysis

4.3       Experts Opinion

5.           Europe Embolization Agents Market– Key Market Dynamics

5.1       Market Drivers

5.1.1        Growing in the Incidence of Tumors and Aneurysms

5.1.1        Rise Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2       Market Restraints

5.2.1        Huge Cost of Embolization Agents

5.3       Market Opportunities

5.3.1        Rising Geriatric Population Base

5.4       Future Trends

5.4.1        Technological Advancements in Embolization Products and Procedures

5.5       Impact analysis

6.           Embolization Agents Market – Europe Analysis

6.1       Europe Embolization Agents Market Revenue Forecast and Analysis

7.           Europe Embolization Agents Market Analysis – By Product

7.1       Overview

7.2       Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)

7.3       Coils

7.3.1        Overview

7.3.2        Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.3.2.1      Detachable Coils

7.3.2.1.1       Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.1.2       Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2      Pushable Coils

7.3.2.2.1       Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.2.2       Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.4       Beads/Particles

7.4.1        Overview

7.4.2        Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.4.2.1      Spherical

7.4.2.1.1       Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.1.2       Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.2.2      Non-Spherical

7.4.2.2.1       Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.2.2       Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.5       Plugs

7.5.1        Overview

7.5.2        Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.6       Detachable Balloons

7.6.1        Overview

7.6.2        Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.7       Glue

7.7.1        Overview

7.7.2        Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.8       Sponge

7.8.1        Overview

7.8.2        Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.9       Liquid Embolics

7.9.1        Overview

7.9.2        Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.10    Sclerosants

7.10.1     Overview

7.10.2     Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.11    Precipitating Agents

7.11.1     Overview

7.11.2     Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.12    Others

7.12.1     Overview

7.12.2     Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

8.           Europe Embolization Agents Market Analysis – By Application

8.1       Overview

8.2       Europe Embolization Agents Market, by Application 2021 & 2028 (%)

8.3       Oncology

8.3.1        Overview

8.3.2        Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.4       Neurology

8.4.1        Overview

8.4.2        Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.5       Urology

8.5.1        Overview

8.5.2        Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.6       Cardiology

8.6.1        Overview

8.6.2        Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.7       Peripheral Vascular Diseases

8.7.1        Overview

8.7.2        Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028  (US$ Million)

8.8       Others

8.8.1        Overview

8.8.2        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Embolization Agents Market Analysis – By End User

9.1       Overview

9.2       Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)

9.3       Hospitals

9.3.1        Overview

9.3.2        Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.4       Cardiac Centers

9.4.1        Overview

9.4.2        Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.5       Ambulatory Surgical Centers

9.5.1        Overview

9.5.2        Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.6       Others

9.6.1        Overview

9.6.2        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Embolization Agents Market – Country Analysis

10.1    Europe: Embolization Agents Market

10.1.1     Overview

10.1.2     Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)

10.1.2.1    Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1    Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2    Germany: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2.1        Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.2        Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3    Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.4    Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2    France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1    France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2    France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2.1        France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.2        France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3    France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.4    France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3    UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1    UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2    UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2.1        UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.2        UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3    UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.4    UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4    Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1    Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2    Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2.1        Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3    Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4    Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.5    Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5    Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1    Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.2    Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.2.1        Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2.2        Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.3    Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.4    Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6    Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1    Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.2    Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.2.1        Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2.2        Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.3    Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.4    Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Europe Embolization Agents Market

11.1    Europe: Impact Assessment Of COVID-19 Pandemic

12.        Europe Embolization Agents Market–Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1    Medtronic

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    Terumo Corporation

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Cook Medical LLC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Boston Scientific Corporation

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Abbott

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Stryker Corporation

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Penumbra, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Merit Medical Systems Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    DePuy Synthes

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 KANEKA CORPORATION

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.        Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms


LIST OF TABLES

Table 1.             Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)

Table 2.             Germany: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)

Table 4.             Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 5.             Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 9.             France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 10.          France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12.          UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 13.          UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 14.          UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 15.          UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 19.          Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 20.          Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 24.          Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 25.          Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028  (USD Million)

Table 30.          Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Organic Developments Done by Companies

Table 33.          Inorganic Developments Done by Companies

Table 34.          Glossary of Terms, Europe Embolization Agents Market

 


LIST OF FIGURES

Figure 1.           Europe Embolization Agents Market Segmentation

Figure 2.           Europe Embolization Agents Market Segmentation, By Country

Figure 3.           Europe Embolization Agents Market Overview

Figure 4.           Beads/ Particles Segment Held the Largest Share of the Product Segment in Europe Embolization Agents Market

Figure 5.           UK to Show Significant Growth During Forecast Period

Figure 6.           Europe and PEST Analysis

Figure 7.           Europe Embolization Agents Market Impact Analysis of Drivers and Restraints

Figure 8.           Europe Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)

Figure 10.        Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Embolization Agents Market, by Application 2021 & 2028 (%)

Figure 21.        Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)

Figure 28.        Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Europe: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)

Figure 33.        Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)

Figure 34.        Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Impact of COVID-19 Pandemic in European Country Markets

 

  1. Abbott
  2. Boston Scientific Corporation
  3. Cook Medical LLC
  4. DePuy Synthes
  5. KANEKA CORPORATION
  6. Medtronic
  7. Merit Medical Systems Inc
  8. Penumbra, Inc.
  9. Stryker Corporation
  10. Terumo Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Embolization Agents Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000